Assessment Of Phosphorylated Her2 Protein As Predictive Biomarker To Stratify Anti-Her2 Treatment In Her2 Non-Amplified Patients - A Translational Study In The Geparquattro And Geparquinto Trials

CANCER RESEARCH(2015)

Cited 1|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined